Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Gross Margin (2022 - 2026)

Envoy Medical's Gross Margin history spans 5 years, with the latest figure at 702.56% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 31126.0% to 702.56% in Q1 2026 year-over-year; TTM through Mar 2026 was 544.87%, a 34157.0% decrease, with the full-year FY2025 number at 406.22%, down 17645.0% from a year prior.
  • Gross Margin hit 702.56% in Q1 2026 for Envoy Medical, down from 642.67% in the prior quarter.
  • Over the last five years, Gross Margin for COCH hit a ceiling of 1228.57% in Q4 2024 and a floor of 2590.0% in Q4 2022.
  • Historically, Gross Margin has averaged 450.82% across 5 years, with a median of 398.75% in 2023.
  • Biggest five-year swings in Gross Margin: skyrocketed 215000bps in 2023 and later plummeted -187124bps in 2025.
  • Tracing COCH's Gross Margin over 5 years: stood at 2590.0% in 2022, then skyrocketed by 83bps to 440.0% in 2023, then skyrocketed by 379bps to 1228.57% in 2024, then plummeted by -152bps to 642.67% in 2025, then dropped by -9bps to 702.56% in 2026.
  • Business Quant data shows Gross Margin for COCH at 702.56% in Q1 2026, 642.67% in Q4 2025, and 864.29% in Q3 2025.